BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2184 participants.

Also called NCT07363161

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,184 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07363161
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07363161. Randomized; no masking; primary purpose treatment. Start 2026-06-17 (actual); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)
Acronym
BASKET BALL
Intervention (Device)
PCI
Lead sponsor
B. Braun Melsungen AG (class: industry)

Record details

Record id
cardio:ct-nct07363161
Content hash
7d576c696fec10d13e73d2c71c6c3dabcbef9ab0c654bc1fa8086925974ad7d2